Family-centered Mental Health Promotion Intervention
CompletedNAResults postedLast updated 17 October 2024
What this trial tests
NA trial testing Problem Management Plus for Immigrants at family settings in Stress, Psychological in 232 participants. Completed in 15 November 2022.
Timeline
17 August 2021
Primary endpoint 15 November 2022
15 November 2022
Quick facts
Lead sponsor
University of Massachusetts, Amherst
Phase
NA
Status
Completed
Study type
INTERVENTIONAL
Allocation
randomized
Design
parallel
Masking
none
Primary purpose
prevention
Enrollment
232
Start date
17 August 2021
Primary completion
15 November 2022
Estimated completion
15 November 2022
Sites
1 location across United States
Drugs / interventions tested
Problem Management Plus for Immigrants at family settings
Talk program with Community Support Service Pamphlet (CSS)
18 and older, any sex, with Stress, Psychological or Stress, Physiological. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Cohen Perceived Stress Scale to Measure StressPrimary· Baseline
The 10-item Cohen Perceived Stress Scale will be used to assess perceived stress at baseline, post-intervention, and 12-week post-intervention. The Cohen Perceived Stress Scale uses a 5-point Likert scale (ranging from 0, "never" to 4, "very often") to assess psychological stress experienced during the past four weeks, including the extent to which situations felt unpredictable, uncomfortable, and overwhelming. The total high scores indicate a worse outcome. The score range is between 0 and 40.
Group
Value
95% CI
Problem Management Plus for Immigrants at Family Settings
23.28
± 3.70
Talk Program With Community Support Service Pamphlet (CSS)
19.31
± 4.87
Hopkins Symptom Checklist-25 to Measure AnxietyPrimary· Baseline
The Hopkins Symptom Checklist-25 (HSCL-25) will be used to measure anxiety and depressive symptoms experienced over the past four weeks at baseline, post-intervention, and 12-week post-intervention. It is composed of a 10-item subscale for anxiety and a 15-item subscale for depression, with each item scored on a Likert scale from 1 (not at all) to 4 (extremely). The higher scores indicate high anxiety or depressive symptoms. The scores range for anxiety between 10 and 40 and depressive symptoms between 15 and 60.
Group
Value
95% CI
Problem Management Plus for Immigrants at Family Settings
21.57
± 3.25
Talk Program With Community Support Service Pamphlet (CSS)
15.37
± 5.08
Hopkins Symptom Checklist-25 to Measure Depressive SymptomsPrimary· Baseline
The Hopkins Symptom Checklist-25 (HSCL-25) will be used to measure anxiety and depressive symptoms experienced over the past four weeks at baseline, post-intervention, and 12-week post-intervention. It is composed of a 10-item subscale for anxiety and a 15-item subscale for depression, with each item scored on a Likert scale from 1 (not at all) to 4 (extremely). The higher scores indicate high anxiety or depressive symptoms. The scores range for anxiety between 10 and 40 and depressive symptoms between 15 and 60.
Group
Value
95% CI
Problem Management Plus for Immigrants at Family Settings
32.11
± 4.89
Talk Program With Community Support Service Pamphlet (CSS)
Cortisol hair test (average hormone levels over the past 3 months) will be used as a biomarker to measure physiological stress. Higher hair cortisol concentrations indicate a higher level of biological stress in the body. The range of values is between 0.799 and 2554.68 pg/mg.
Group
Value
95% CI
Problem Management Plus for Immigrants at Family Settings
349.37
± 2627.98
Talk Program With Community Support Service Pamphlet (CSS)
78.35
± 324.36
Sponsor's own description
Goal: The long-term goal of the proposed research program is to test the effectiveness of a preventative behavioral intervention and to scale it up for use with broader immigrant populations to reduce stress and mental health disorders.
Intervention: This study plan to adapt the World Health Organization developed Problem Management Plus (PMP), an evidence based, multi-component, behavioral intervention including breathing, problem solving, behavioral activation, and social support for immigrants.
Hypothesis: Immigrants in the Problem Management Plus for Immigrants (PMP-I) will have significantly lower levels of stress and anxious/depressive symptoms as compared to immigrants in the talk program with Community Support Service pamphlets (CSS).
Objective: The current study aims to pilot test the feasibility and acceptability of PMP-I among Bhutanese immigrants 18 years and older living in the Massachusetts.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety
· NA
· recruiting
NCT07255365 — Virtual Reality-Based 360° Clinic Walkthrough for Reducing Examination Anxiety in Preschool Children
· NA
· recruiting
NCT07313735 — The Effect of Cartoon Character-Printed Band Use During Burn Dressing on Fear, Stress, Pain, and Physiological Parameter
· NA
· recruiting
NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees
· recruiting
NCT06771167 — Building Community Resilience Program
· NA
· recruiting
Other University of Massachusetts, Amherst trials
Trials by the same sponsor.
NCT07211373 — Advancing Student Suicide Interventions With Scalable Technologies
· NA
· enrolling by invitation
NCT06990997 — Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Amherst
Last refreshed: 17 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04453709.